186 related articles for article (PubMed ID: 24846011)
1. Inhibition of HERG potassium channels by domiphen bromide and didecyl dimethylammonium bromide.
Long Y; Chen W; Lin Z; Sun H; Xia M; Zheng W; Li Z
Eur J Pharmacol; 2014 Aug; 737():202-9. PubMed ID: 24846011
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of HERG potassium channel inhibition by tetra-n-octylammonium bromide and benzethonium chloride.
Long Y; Lin Z; Xia M; Zheng W; Li Z
Toxicol Appl Pharmacol; 2013 Mar; 267(2):155-66. PubMed ID: 23313619
[TBL] [Abstract][Full Text] [Related]
3. Discovery and electrophysiological characterization of SKF-32802: A novel hERG agonist found through a large-scale structural similarity search.
Donovan BT; Bandyopadhyay D; Duraiswami C; Nixon CJ; Townsend CY; Martens SF
Eur J Pharmacol; 2018 Jan; 818():306-327. PubMed ID: 29050968
[TBL] [Abstract][Full Text] [Related]
4. Propofol inhibits hERG K
Han SN; Jing Y; Yang LL; Zhang Z; Zhang LR
Eur J Pharmacol; 2016 Nov; 791():168-178. PubMed ID: 27575519
[TBL] [Abstract][Full Text] [Related]
5. hERG channel blockade by externally applied quaternary ammonium derivatives.
Choi KH; Song C; Shin D; Park S
Biochim Biophys Acta; 2011 Jun; 1808(6):1560-6. PubMed ID: 21320466
[TBL] [Abstract][Full Text] [Related]
6. Effects of cariprazine on hERG 1A and hERG 1A/3.1 potassium channels.
Lee HJ; Choi BH; Choi JS; Hahn SJ
Eur J Pharmacol; 2019 Jul; 854():92-100. PubMed ID: 30954564
[TBL] [Abstract][Full Text] [Related]
7. Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.
Xia M; Shahane SA; Huang R; Titus SA; Shum E; Zhao Y; Southall N; Zheng W; Witt KL; Tice RR; Austin CP
Toxicol Appl Pharmacol; 2011 May; 252(3):250-8. PubMed ID: 21362439
[TBL] [Abstract][Full Text] [Related]
8. Endoxifen, the active metabolite of tamoxifen, inhibits cloned hERG potassium channels.
Chae YJ; Lee KJ; Lee HJ; Sung KW; Choi JS; Lee EH; Hahn SJ
Eur J Pharmacol; 2015 Apr; 752():1-7. PubMed ID: 25680947
[TBL] [Abstract][Full Text] [Related]
9. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.
Gillie DJ; Novick SJ; Donovan BT; Payne LA; Townsend C
J Pharmacol Toxicol Methods; 2013; 67(1):33-44. PubMed ID: 23103595
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
[TBL] [Abstract][Full Text] [Related]
11. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
12. Molecular Insights into hERG Potassium Channel Blockade by Lubeluzole.
Gualdani R; Cavalluzzi MM; Tadini-Buoninsegni F; Convertino M; Gailly P; Stary-Weinzinger A; Lentini G
Cell Physiol Biochem; 2018; 45(6):2233-2245. PubMed ID: 29550817
[TBL] [Abstract][Full Text] [Related]
13. Halide ion effects on human Ether-à-go-go related gene potassium channel properties.
Zeng H; Balasubramanian B; Penniman JR; Kinose F; Salata JJ; Lagrutta A
Assay Drug Dev Technol; 2013; 11(9-10):544-50. PubMed ID: 24147984
[TBL] [Abstract][Full Text] [Related]
14. Assessing hERG pore models as templates for drug docking using published experimental constraints: the inactivated state in the context of drug block.
Dempsey CE; Wright D; Colenso CK; Sessions RB; Hancox JC
J Chem Inf Model; 2014 Feb; 54(2):601-12. PubMed ID: 24471705
[TBL] [Abstract][Full Text] [Related]
15. Effect of azelastine on cardiac repolarization of guinea-pig cardiomyocytes, hERG K⁺ channel, and human L-type and T-type Ca²⁺ channel.
Park MH; Lee SH; Chu DH; Won KH; Choi BH; Choe H; Jo SH
J Pharmacol Sci; 2013 Sep; 123(1):67-77. PubMed ID: 24005046
[TBL] [Abstract][Full Text] [Related]
16. The evolutionarily conserved residue A653 plays a key role in HERG channel closing.
Stepanovic SZ; Potet F; Petersen CI; Smith JA; Meiler J; Balser JR; Kupershmidt S
J Physiol; 2009 Jun; 587(Pt 11):2555-66. PubMed ID: 19406877
[TBL] [Abstract][Full Text] [Related]
17. Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells.
Zhao J; Wang Q; Xu J; Zhao J; Liu G; Peng S
Eur J Pharmacol; 2011 Jun; 660(2-3):259-67. PubMed ID: 21497594
[TBL] [Abstract][Full Text] [Related]
18. Mesoridazine: an open-channel blocker of human ether-a-go-go-related gene K+ channel.
Su Z; Martin R; Cox BF; Gintant G
J Mol Cell Cardiol; 2004 Jan; 36(1):151-60. PubMed ID: 14734057
[TBL] [Abstract][Full Text] [Related]
19. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel.
Schmalhofer WA; Swensen AM; Thomas BS; Felix JP; Haedo RJ; Solly K; Kiss L; Kaczorowski GJ; Garcia ML
Assay Drug Dev Technol; 2010 Dec; 8(6):714-26. PubMed ID: 21158686
[TBL] [Abstract][Full Text] [Related]
20. Effects of phosphodiesterase (PDE) inhibitors on human ether-a-go-go related gene (hERG) channel activity.
Yunomae K; Ichisaki S; Matsuo J; Nagayama S; Fukuzaki K; Nagata R; Kito G
J Appl Toxicol; 2007; 27(1):78-85. PubMed ID: 17146843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
